When Your Immune System Might Play a Role in Pregnancy: Exploring LMIT as an Emerging Option

Trying to conceive can be one of life’s most meaningful experiences — but for some couples, it’s also one of the most difficult. If you've experienced multiple pregnancy losses, failed implantation attempts, or have been told your infertility is “unexplained,” you may be exploring additional avenues of support.

One emerging area of interest is the potential role of the immune system in reproductive outcomes. At The Infusion Centre Gold Coast, we offer Lymphocyte Membrane Immunotherapy (LMIT) as a referral-based, investigational therapy that is being studied in certain cases where immune involvement in infertility is suspected.

What Is LMIT?

LMIT is part of a growing area of interest known as reproductive immunology, which explores how the immune system may interact with a developing embryo. While LMIT remains an experimental approach, some specialists consider it for individuals experiencing:

• Recurrent miscarriage

• Repeated implantation failure

• Unexplained infertility

LMIT is not currently part of standard fertility protocols in Australia, and it is not approved by the TGA. Its use is typically coordinated by fertility specialists with experience in reproductive immunology.

Next Steps

LMIT involves collecting blood from the male partner, processing it to extract specific membrane components from lymphocytes, and then administering it via intradermal injection to the female partner. The therapy is being explored for its potential role in modulating immune recognition, particularly in cases where immune system activation may affect implantation or early pregnancy.

Some early research and observational studies have investigated how LMIT may influence immune responses, such as those involving natural killer (NK) cells, T-helper ratios, or regulatory T-cell function. More rigorous evidence will be required before it can be considered a standard treatment.

If your fertility specialist believes immune dysregulation could be a factor in your fertility journey, and LMIT is recommended you can click here to see the simple steps of how we at The Infusion Centre can support you and your partner.

What are some common questions we are asked?

Q: Who might benefit from LMIT?

A: LMIT may be considered for people experiencing recurrent miscarriage, repeated IVF implantation failure, or unexplained infertility. A growing body of literature suggests that immune imbalances, particularly involving NK cell activity, Th1/Th2 ratios, and regulatory T-cell responses, may affect implantation and early pregnancy (Kwakkel et al., Am J Reprod Immunol, 2021). Suitability for LMIT is assessed by a qualified fertility specialist.

Q: How does LMIT support fertility?

A: LMIT introduces processed lymphocyte membrane components from the male partner into the female partner via injection. This may help the maternal immune system become more "familiar" with paternal antigens and tolerate the embryo. Studies suggest this process may stimulate blocking antibodies (e.g. PIBF, Ab2, anti-TCR antibodies), modulate NK cell activity, and shift immune responses to a more pregnancy-supportive profile (e.g. reduced IL-2 receptor expression and increased Treg function).

Q: How many LMIT sessions are needed?

A: Treatment protocols vary. Most patients receive 1–2 priming doses before trying to conceive, with possible booster doses during early pregnancy milestones (e.g. positive hCG, heartbeat scan). Your fertility specialist will customise the schedule based on your clinical history and lab monitoring.

Q: Are there risks or side effects?

A: Side effects are generally mild and may include local redness, swelling, or discomfort at the injection site. Serious reactions are rare but will be discussed with you during your consultation.

Q: Is LMIT an TGAB / FDA approved treatment?

A: LMIT is considered experimental and is not TGA- or FDA-approved. It is considered investigational and should only be undertaken under medical supervision with appropriate counselling and informed consent.

Q: Who should not receive LMIT?

A: Your referring doctor will assess whether LMIT is safe for you based on your medical history. LMIT may not be suitable for patients with:

• Active or chronic infections

• Autoimmune skin conditions (e.g. lupus)

• Cancer or undergoing chemotherapy

• Severe clotting disorders or platelet abnormalities

• Current corticosteroid use or immunosuppressive therapies.

Still have questions? We're here to help make your next steps simple and supported.📄 Want to learn more? Browse our FAQs.

Next Steps

If your fertility specialist has recommended LMIT as part of your broader care plan, and you’re based on the Gold Coast, The Infusion Centre offers referral-based support in a nurse- and midwife-led setting. We work closely with your medical team to ensure every step is aligned with your clinical needs.

Contact Us

The Infusion Centre 

📍 306 Olsen Avenue, Parkwood QLD 4214 

📞 +61 449 916 829 

📧 info@theinfusioncentre.com.au 

🌐 theinfusioncentre.com.au

Disclaimer: This information is intended for educational purposes only and does not constitute medical advice. Lymphocyte Membrane Immunotherapy (LMIT) is an investigational therapy and is not approved by the TGA. It is only provided at The Infusion Centre on referral from a qualified fertility specialist. Outcomes vary. Please consult your healthcare provider to assess whether this approach is appropriate for your situation.

LMIT is an investigational treatment. Outcomes vary between individuals. Always consult your healthcare provider to determine what is best for your situation.